申请人:Kazmierski Mieczyslaw Wieslaw
公开号:US20060229336A1
公开(公告)日:2006-10-12
The present invention relates to compounds of formula (I) or a pharmaceutically acceptable derivatives thereof, useful in the treatment of prophylazis of CCR5-related diseases and disorders, for example, in the inhibition of HIV replication, the prevention or treatment of HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).
本发明涉及式(I)化合物或其药学上可接受的衍生物,用于预防CCR5相关疾病和障碍的治疗,例如,抑制HIV复制,预防或治疗HIV感染,以及治疗由此产生的获得性免疫缺陷综合症(AIDS)。